<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2022-7.3.11</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-3555</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФЕКЦИОННЫЕ БОЛЕЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INFECTIOUS DISEASES</subject></subj-group></article-categories><title-group><article-title>Прогнозирование тяжести вирусного бронхиолита у детей</article-title><trans-title-group xml:lang="en"><trans-title>Predicting the severity of viral bronchiolitis in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2493-3740</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бочкарева</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bochkareva</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p> ассистент кафедры детских инфекций</p><p>672000, г. Чита, ул. Горького, 39а, Россия </p></bio><bio xml:lang="en"><p> Teaching Assistant at the Department of Pediatric Infections</p><p>Gorkogo str. 39a, Chita 672000, Russian Federation </p></bio><email xlink:type="simple">larisa.bochkareva.1992@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2109-4643</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мироманова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Miromanova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> доктор медицинских наук, доцент, заведующая кафедрой детских инфекций</p><p>672000, г. Чита, ул. Горького, 39а, Россия </p></bio><bio xml:lang="en"><p> Dr. Sc. (Med.), Head of the Department of Pediatric Infections</p><p>Gorkogo str. 39a, Chita 672000, Russian Federation </p></bio><email xlink:type="simple">detinf-chita@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1432-1844</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мироманов</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Miromanov</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p> доктор медицинских наук, профессор, заведующий кафедрой травматологии и ортопедии</p><p>672000, г. Чита, ул. Горького, 39а, Россия </p></bio><bio xml:lang="en"><p> Dr. Sc. (Med.), Professor, Head of the Department of Traumatology and Orthopedics</p><p> Gorkogo str. 39a, Chita 672000, Russian Federation </p></bio><email xlink:type="simple">miromanov_a@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава России</institution></aff><aff xml:lang="en"><institution>Chita State Medical Academy </institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава России</institution></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>05</day><month>07</month><year>2022</year></pub-date><volume>7</volume><issue>3</issue><fpage>98</fpage><lpage>109</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бочкарева Л.С., Мироманова Н.А., Мироманов А.М., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Бочкарева Л.С., Мироманова Н.А., Мироманов А.М.</copyright-holder><copyright-holder xml:lang="en">Bochkareva L.S., Miromanova N.A., Miromanov A.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/3555">https://www.actabiomedica.ru/jour/article/view/3555</self-uri><abstract><p>Острый вирусный бронхиолит одна из частых причин госпитализации и смертности, особенно среди детей первого года жизни, имеющих факторы риска (недоношенность, врождённые пороки сердца, бронхолёгочная дисплазия, иммуносупрессия). В качестве факторов, ассоциированных с тяжестью бронхиолита, наряду с традиционными, могут рассматриваться однонуклеотидные полиморфизмы генов молекул иммунного ответа.Цель исследования. На основе анализа клинико-лабораторных и молекулярно-генетических параметров выявить прогностические критерии тяжёлого острого вирусного бронхиолита у детей.Материалы и методы. В исследование включено 106 детей с острым вирусным бронхиолитом (тяжёлой степени – 34, нетяжёлой степени – 72), этиологией которого в 67,9 % явился респираторно-синцитиальный вирус. В качестве прогностических критериев оценивалось 47 анамнестических, клинических, традиционных лабораторных и молекулярно-генетических параметров. Определение SNP генов цитокинов IL-4 (С-589Т), IL-10 (G-1082A), IL-10 (C-592A), IL-10 (C-819T), TNF-α (G-308A), IL-17A (G197A), IL-17F (His161Arg), TLR2-753ArgGln, TLR6-Ser249Pro в венозной крови осуществляли методом полимеразной цепной реакции.Результаты. Дополнительным критерием риска развития тяжёлого бронхиолита может служить мутантный генотип (АА) SNP гена IL-10 (C-592A), выявлявшийся исключительно в группе больных тяжёлым бронхиолитом, увеличивая риск развития тяжёлого заболевания в 16,11 раза (ОШ = 16,11; 95% ДИ: 0,81–121,22, р = 0,02) в совокупности с уже установленными модифицирующими факторами: наличием врождённого порока сердца, бронхолёгочной дисплазии, недоношенностью, массой тела при рождении &lt; 1500 г. На основании комплексной оценки установленных факторов риска разработан метод, позволяющий рассчитать вероятность развития тяжёлого острого вирусного бронхиолита.Заключение. Использование разработанного способа прогнозирования позволит не только повысить вероятность развития тяжёлого острого вирусного бронхиолита у детей, но и определить приоритетную группу среди детей с предикторами тяжёлого развития вирусного бронхиолита для первоочередной иммунопрофилактики против РС-вирусной инфекции. </p></abstract><trans-abstract xml:lang="en"><p>Acute viral bronchiolitis is one of the common causes of hospitalization and mortality, especially among children in the first year of life who have risk factors (prematurity, congenital heart defects, bronchopulmonary dysplasia, immunosuppression). As factors associated with the severe course of bronchiolitis, along with the traditional ones, single nucleotide polymorphisms of the genes of the immune response molecules can be considered.The aim. Based on the analysis of clinical, laboratory and molecular genetic parameters, to identify prognostic criteria for the severe course of acute viral bronchiolitis in children.Materials and methods. The study included 106 children with acute viral bronchiolitis (severe course – 34, mild course – 72), the etiology of which in 67.9 % was respiratory syncytial virus. Forty-seven anamnestic, clinical, traditional laboratory and molecular genetic parameters were assessed as prognostic criteria. Determination of SNP genes of cytokines IL-4 (C-589T), IL-10 (G-1082A), IL-10 (C-592A), IL-10 (C-819T), TNF-α (G-308A), IL-17A (G197A), IL-17F (His161Arg), TLR2-753ArgGln, TLR6-Ser249Pro in venous blood was carried out by the polymerase chain reaction method.Results. An additional criterion for the risk of developing a severe course of bronchiolitis can be the mutant genotype (AA) SNP of the IL-10 gene (C-592A), which was detected exclusively in the group of patients with severe bronchiolitis, increasing the risk of developing a severe disease by 16.11 times (OR = 16.11; 95 % CI: 0.81–121.22, p = 0.02) in conjunction with already established modifying factors: the presence of congenital heart disease, bronchopulmonary dysplasia, prematurity, birth weight &lt; 1500 g. Based on a comprehensive assessment of the established risk factors, a method has been developed that allows calculate the likelihood of developing a severe course of acute viral bronchiolitis. Conclusion. The use of the developed prediction method will not only increase the likelihood of developing severe acute viral bronchiolitis in children, but also determine the priority group among children with predictors of severe viral bronchiolitis for priority immunoprophylaxis against RS-virus infection.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>бронхиолит</kwd><kwd>тяжесть</kwd><kwd>факторы риска</kwd><kwd>дети</kwd><kwd>полиморфизм</kwd><kwd>цитокины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bronchiolitis</kwd><kwd>severity</kwd><kwd>risk factors</kwd><kwd>children</kwd><kwd>polymorphism</kwd><kwd>cytokine</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Союз педиатров России. Острый бронхиолит: клинические рекомендации. М.; 2021.</mixed-citation><mixed-citation xml:lang="en">Union of Pediatricians of Russia. Acute bronchiolitis: Clinical guidelines. Moscow; 2021. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Smith DK, Seales S, Budzik C. Respiratory syncytial virus bronchiolitis in children. Am Fam Physician. 2017; 95(2): 94-99.</mixed-citation><mixed-citation xml:lang="en">Smith DK, Seales S, Budzik C. Respiratory syncytial virus bronchiolitis in children. Am Fam Physician. 2017; 95(2): 94-99.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014; 134(5): e1474-e1502. doi: 10.1542/peds.2014-2742</mixed-citation><mixed-citation xml:lang="en">Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014; 134(5): e1474-e1502. doi: 10.1542/peds.2014-2742</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet. 2010; 375(9725): 1545-1555. doi: 10.1016/S0140-6736(10)60206-1</mixed-citation><mixed-citation xml:lang="en">Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet. 2010; 375(9725): 1545-1555. doi: 10.1016/S0140-6736(10)60206-1</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Schroeder AR, Mansbach JM. Recent evidence on the management of bronchiolitis. Curr Opin Pediatr. 2014; 26(3): 328-333. doi: 10.1097/MOP.0000000000000090</mixed-citation><mixed-citation xml:lang="en">Schroeder AR, Mansbach JM. Recent evidence on the management of bronchiolitis. Curr Opin Pediatr. 2014; 26(3): 328-333. doi: 10.1097/MOP.0000000000000090</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Бочкарева Л.С., Мироманова Н.А., Казанцев В.Н., Прокопенко О.В. Особенности течения респираторно-синцитиальной вирусной инфекции среди госпитализированных пациентов детского возраста из групп риска. Забайкальский медицинский журнал. 2018; 2: 57-58.</mixed-citation><mixed-citation xml:lang="en">Bochkareva LS, Miromanova NA, Kazantsev VN, Prokopenko OV. Features of the course of respiratory syncytial viral infection among hospitalized pediatric patients from risk groups. Zabaykal’skiy meditsinskiy zhurnal. 2018; 2: 57-58. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kenmoe S, Kengne-Nde C, Ebogo-Belobo JT, Mbaga DS, Fatawou Modiyinji A, Njouom R. Systematic review and meta-analysis of the prevalence of common respiratory viruses in children &lt; 2 years with bronchiolitis in the pre-COVID-19 pandemic era. PLoS One. 2020; 15(11): e0242302. doi: 10.1371/journal.pone.0242302</mixed-citation><mixed-citation xml:lang="en">Kenmoe S, Kengne-Nde C, Ebogo-Belobo JT, Mbaga DS, Fatawou Modiyinji A, Njouom R. Systematic review and meta-analysis of the prevalence of common respiratory viruses in children &lt; 2 years with bronchiolitis in the pre-COVID-19 pandemic era. PLoS One. 2020; 15(11): e0242302. doi: 10.1371/journal.pone.0242302</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dumas O, Mansbach JM, Jartti T, Hasegawa K, Sullivan AF, Piedra PA, et al. A clustering approach to identify severe bronchiolitis profiles in children. Thorax. 2016; 71(8): 712-718. doi: 10.1136/thoraxjnl-2016-208535</mixed-citation><mixed-citation xml:lang="en">Dumas O, Mansbach JM, Jartti T, Hasegawa K, Sullivan AF, Piedra PA, et al. A clustering approach to identify severe bronchiolitis profiles in children. Thorax. 2016; 71(8): 712-718. doi: 10.1136/thoraxjnl-2016-208535</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hasegawa K, Stewart CJ, Celedón JC, Mansbach JM, Tierney C, Camargo CA Jr. Circulating 25-hydroxyvitamin D, nasopharyngeal airway metabolome, and bronchiolitis severity. Allergy. 2018; 73(5): 1135-4110. doi: 10.1111/all.13379</mixed-citation><mixed-citation xml:lang="en">Hasegawa K, Stewart CJ, Celedón JC, Mansbach JM, Tierney C, Camargo CA Jr. Circulating 25-hydroxyvitamin D, nasopharyngeal airway metabolome, and bronchiolitis severity. Allergy. 2018; 73(5): 1135-4110. doi: 10.1111/all.13379</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Friedman JN, Rieder MJ, Walton JM. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014; 19(9): 485-498. doi: 10.1093/pch/19.9.485</mixed-citation><mixed-citation xml:lang="en">Friedman JN, Rieder MJ, Walton JM. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014; 19(9): 485-498. doi: 10.1093/pch/19.9.485</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Checchia PA, Paes B, Bont L, Manzoni P, Simões EAF, Fauroux B, et al. Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among infants with congenital heart disease. Infect Dis Ther. 2017; 6(1): 37-56. doi: 10.1007/s40121-016-0142-x</mixed-citation><mixed-citation xml:lang="en">Checchia PA, Paes B, Bont L, Manzoni P, Simões EAF, Fauroux B, et al. Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among infants with congenital heart disease. Infect Dis Ther. 2017; 6(1): 37-56. doi: 10.1007/s40121-016-0142-x</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Manzoni P, Figueras-Aloy J, Simões EAF, Checchia PA, Fauroux B., Bont L, et al. Defining the incidence and associated morbidity and mortality of severe respiratory syncytial virus infection among children with chronic diseases. Infect Dis Ther. 2017; 6(3): 383-411. doi: 10.1007/s40121-017-0160-3</mixed-citation><mixed-citation xml:lang="en">Manzoni P, Figueras-Aloy J, Simões EAF, Checchia PA, Fauroux B., Bont L, et al. Defining the incidence and associated morbidity and mortality of severe respiratory syncytial virus infection among children with chronic diseases. Infect Dis Ther. 2017; 6(3): 383-411. doi: 10.1007/s40121-017-0160-3</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Siezen CL, Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van’t Slot R, et al. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr Infect Dis J. 2009; 28(4): 333‐335. doi: 10.1097/INF.0b013e31818e2aa9</mixed-citation><mixed-citation xml:lang="en">Siezen CL, Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van’t Slot R, et al. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr Infect Dis J. 2009; 28(4): 333‐335. doi: 10.1097/INF.0b013e31818e2aa9</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Huang J, Zhang M, Zhang X, Lu A, Wang L, Chen C. IFN‐gamma CA microsatellite polymorphism is associated with susceptibility to respiratory syncytial virus infection and severity. Acta Paediatr. 2014; 103(12): 544-547. doi: 10.1111/apa.12767</mixed-citation><mixed-citation xml:lang="en">Huang J, Zhang M, Zhang X, Lu A, Wang L, Chen C. IFN‐gamma CA microsatellite polymorphism is associated with susceptibility to respiratory syncytial virus infection and severity. Acta Paediatr. 2014; 103(12): 544-547. doi: 10.1111/apa.12767</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Faber TE, Schuurhof A, Vonk A, Koppelman GH, Hennus MP, Kimpen JLL, et al. IL1RL1 gene variants and nasopharyngeal IL1RL‐a levels are associated with severe RSV bronchiolitis: A multicenter cohort study. PLoS One. 2012; 7(5): e34364. doi: 10.1371/journal.pone.0034364</mixed-citation><mixed-citation xml:lang="en">Faber TE, Schuurhof A, Vonk A, Koppelman GH, Hennus MP, Kimpen JLL, et al. IL1RL1 gene variants and nasopharyngeal IL1RL‐a levels are associated with severe RSV bronchiolitis: A multicenter cohort study. PLoS One. 2012; 7(5): e34364. doi: 10.1371/journal.pone.0034364</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fan R, Wen B, Liu W, Zhang J, Liu C, Fan C, et al. Altered regulatory cytokine profiles in cases of pediatric respiratory syncytial virus infection. Cytokine. 2018; 103: 57-62. doi: 10.1016/j.cyto.2017.12.028</mixed-citation><mixed-citation xml:lang="en">Fan R, Wen B, Liu W, Zhang J, Liu C, Fan C, et al. Altered regulatory cytokine profiles in cases of pediatric respiratory syncytial virus infection. Cytokine. 2018; 103: 57-62. doi: 10.1016/j.cyto.2017.12.028</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus. Rev Med Virol. 2021; 31(6): e22234. doi: 10.1002/rmv.2234</mixed-citation><mixed-citation xml:lang="en">Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus. Rev Med Virol. 2021; 31(6): e22234. doi: 10.1002/rmv.2234</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Marr N, Hirschfeld AF, Lam A, Wang S, Lavoie PM, Turvey SE. Assessment of genetic associations between common single nucleotide polymorphisms in RIG-I-like receptor and IL-4 signaling genes and severe respiratory syncytial virus infection in children: A candidate gene case-control study. PLoS One. 2014; 9(6): e100269. doi: 10.1371/journal.pone.0100269</mixed-citation><mixed-citation xml:lang="en">Marr N, Hirschfeld AF, Lam A, Wang S, Lavoie PM, Turvey SE. Assessment of genetic associations between common single nucleotide polymorphisms in RIG-I-like receptor and IL-4 signaling genes and severe respiratory syncytial virus infection in children: A candidate gene case-control study. PLoS One. 2014; 9(6): e100269. doi: 10.1371/journal.pone.0100269</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Patel JA, Nair S, Ochoa EE, Huda R, Roberts NJ, Chonmaitree T. Interleukin-6–¹⁷⁴ and tumor necrosis factor α–³⁰⁸ polymorphisms enhance cytokine production by human macrophages exposed to respiratory viruses. J Interferon Cytokine Res. 2010; 30(12): 917-921. doi: 10.1089/jir.2010.0033</mixed-citation><mixed-citation xml:lang="en">Patel JA, Nair S, Ochoa EE, Huda R, Roberts NJ, Chonmaitree T. Interleukin-6–¹⁷⁴ and tumor necrosis factor α–³⁰⁸ polymorphisms enhance cytokine production by human macrophages exposed to respiratory viruses. J Interferon Cytokine Res. 2010; 30(12): 917-921. doi: 10.1089/jir.2010.0033</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Drysdale SB, Alcazar M, Wilson T, Smith M, Zuckerman M, Hodemaekers HM, et al. Functional and genetic predisposition to rhinovirus lower respiratory tract infections in prematurely born infants. Eur J Pediatr. 2016; 175(12): 1943-1949. doi: 10.1007/s00431-016-2780-0</mixed-citation><mixed-citation xml:lang="en">Drysdale SB, Alcazar M, Wilson T, Smith M, Zuckerman M, Hodemaekers HM, et al. Functional and genetic predisposition to rhinovirus lower respiratory tract infections in prematurely born infants. Eur J Pediatr. 2016; 175(12): 1943-1949. doi: 10.1007/s00431-016-2780-0</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Korppi M, Nuolivirta K, Lauhkonen E, Holster A, Teräsjärvi J, Vuononvirta J, et al. IL-10 gene polymorphism is associated with preschool atopy and early-life recurrent wheezing after bronchiolitis in infancy. Pediatr Pulmonol. 2017; 52(1): 14-20. doi: 10.1002/ppul.23489</mixed-citation><mixed-citation xml:lang="en">Korppi M, Nuolivirta K, Lauhkonen E, Holster A, Teräsjärvi J, Vuononvirta J, et al. IL-10 gene polymorphism is associated with preschool atopy and early-life recurrent wheezing after bronchiolitis in infancy. Pediatr Pulmonol. 2017; 52(1): 14-20. doi: 10.1002/ppul.23489</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lauhkonen E, Koponen P, Teräsjärvi J, Gröndahl-YliHannuksela K, Vuononvirta J, Nuolivirta K, et al. IL-10 gene polymorphisms are associated with post-bronchiolitis lung function abnormalities at six years of age. PLoS One. 2015; 10(10): e0140799. doi: 10.1371/journal.pone.0140799</mixed-citation><mixed-citation xml:lang="en">Lauhkonen E, Koponen P, Teräsjärvi J, Gröndahl-YliHannuksela K, Vuononvirta J, Nuolivirta K, et al. IL-10 gene polymorphisms are associated with post-bronchiolitis lung function abnormalities at six years of age. PLoS One. 2015; 10(10): e0140799. doi: 10.1371/journal.pone.0140799</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Pinto LA, DE Azeredo Leitão LA, Mocellin M, Acosta P, Caballero MT, Libster R, et al. IL-8/IL-17 gene variations and the susceptibility to severe viral bronchiolitis. Epidemiol Infect. 2017; 145(4): 642-646. doi: 10.1017/S0950268816002648</mixed-citation><mixed-citation xml:lang="en">Pinto LA, DE Azeredo Leitão LA, Mocellin M, Acosta P, Caballero MT, Libster R, et al. IL-8/IL-17 gene variations and the susceptibility to severe viral bronchiolitis. Epidemiol Infect. 2017; 145(4): 642-646. doi: 10.1017/S0950268816002648</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lang TA, Altman DG. Statistical analyses and method in the published literature: The SAMPL guidelines. Medical Writing. 2016; 25(3): 31-36. doi: 10.18243/eon/2016.9.7.4</mixed-citation><mixed-citation xml:lang="en">Lang TA, Altman DG. Statistical analyses and method in the published literature: The SAMPL guidelines. Medical Writing. 2016; 25(3): 31-36. doi: 10.18243/eon/2016.9.7.4</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров ВА. Алгоритмы статистического анализа количественных признаков в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020; 1: 140-150. doi: 10.52485/19986173_2020_1_140</mixed-citation><mixed-citation xml:lang="en">Mudrov VA. Algorithms for statistical analysis of quantitative features in biomedical research using the SPSS software package. Zabaykal’skiy meditsinskiy zhurnal. 2020; 1: 140-150. (In Russ.). doi: 10.52485/19986173_2020_1_140</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров ВА. Алгоритмы статистического анализа качественных признаков в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020; 1: 151-163. doi: 10.52485/19986173_2020_1_151</mixed-citation><mixed-citation xml:lang="en">Mudrov VA. Algorithms for statistical analysis of qualitative features in biomedical research using the SPSS software package. Zabaykal’skiy meditsinskiy zhurnal. 2020; 1: 151-163. (In Russ.). doi: 10.52485/19986173_2020_1_151</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров ВА. Алгоритмы регрессионного анализа в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020; 2: 177-190. doi: 10.52485/19986173_2020_2_177</mixed-citation><mixed-citation xml:lang="en">Mudrov VA. Regression analysis algorithms in biomedical research using the SPSS software package. Zabaykal’skiy meditsinskiy zhurnal. 2020; 2: 177-190. (In Russ.). doi: 10.52485/19986173_2020_2_177</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров ВА. Алгоритмы применения ROC-анализа в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2021; 1: 148-153. doi: 10.52485/19986173_2021_1_148</mixed-citation><mixed-citation xml:lang="en">Mudrov VA. Algorithms for the application of ROC analysis in biomedical research using the SPSS software package. Zabaykal’skiy meditsinskiy zhurnal. 2021; 1: 148-153. (In Russ.). doi: 10.52485/19986173_2021_1_148</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Masarweh K, Gur M, Leiba R, Bar-Yoseph R, Toukan Y, Nir V, et al. Factors predicting length of stay in bronchiolitis. Respir Med. 2020; 161: 105824. doi: 10.1016/j.rmed.2019.105824</mixed-citation><mixed-citation xml:lang="en">Masarweh K, Gur M, Leiba R, Bar-Yoseph R, Toukan Y, Nir V, et al. Factors predicting length of stay in bronchiolitis. Respir Med. 2020; 161: 105824. doi: 10.1016/j.rmed.2019.105824</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Баранов А.А., Намазова-Баранова Л.С., Таточенко В.К., Давыдова И.В., Бакрадзе М.Д., Вишнёва Е.А. и др. Острый бронхиолит у детей. Современные подходы к диагностике и терапии. Педиатрическая фармакология. 2015; 12(4): 441-446. doi: 10.15690/pf.v12i4.1426</mixed-citation><mixed-citation xml:lang="en">Baranov AA, Namazova-Baranova LS, Tatochenko VK, Davydova IV, Bakradze MD, Vishneva EA, et al. Acute bronchiolitis in children. Modern approaches to diagnostics and therapy. Pediatric Pharmacology. 2015; 4(12): 441-446. (In Russ.). doi: 10.15690/pf.v12i4.1426</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Fauroux B, Hascoët JM, Jarreau PH, Magny JF, Rozé JC, Saliba E, et al. Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013). PLoS One. 2020; 15(3): e0229766. doi: 10.1371/journal.pone.0229766</mixed-citation><mixed-citation xml:lang="en">Fauroux B, Hascoët JM, Jarreau PH, Magny JF, Rozé JC, Saliba E, et al. Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013). PLoS One. 2020; 15(3): e0229766. doi: 10.1371/journal.pone.0229766</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Robledo-Aceves M, Moreno-Peregrina MJ, VelardeRivera F, Ascencio-Esparza E, Preciado-Figueroa FM, Caniza MA, et al. Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department. Medicine (Baltimore). 2018; 97(9): e0057. doi: 10.1097/MD.0000000000010057</mixed-citation><mixed-citation xml:lang="en">Robledo-Aceves M, Moreno-Peregrina MJ, VelardeRivera F, Ascencio-Esparza E, Preciado-Figueroa FM, Caniza MA, et al. Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department. Medicine (Baltimore). 2018; 97(9): e0057. doi: 10.1097/MD.0000000000010057</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Praznik A, Vinšek N, Prodan A, Erčulj V, Pokorn M, Mrvič T, et al. Risk factors for bronchiolitis severity: A retrospective review of patients admitted to the university hospital from central region of Slovenia. Influenza Other Respir Viruses. 2018; 12(6): 765-771. doi: 10.1111/irv.12587</mixed-citation><mixed-citation xml:lang="en">Praznik A, Vinšek N, Prodan A, Erčulj V, Pokorn M, Mrvič T, et al. Risk factors for bronchiolitis severity: A retrospective review of patients admitted to the university hospital from central region of Slovenia. Influenza Other Respir Viruses. 2018; 12(6): 765-771. doi: 10.1111/irv.12587</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Murray J, Bottle A, Sharland M, Modi N, Aylin P, Majeed A, et al. Risk factors for hospital admission with RSV bronchiolitis in England: A population-based birth cohort study. PLoS One. 2014; 9(2): e8918. doi: 10.1371/journal.pone.0089186</mixed-citation><mixed-citation xml:lang="en">Murray J, Bottle A, Sharland M, Modi N, Aylin P, Majeed A, et al. Risk factors for hospital admission with RSV bronchiolitis in England: A population-based birth cohort study. PLoS One. 2014; 9(2): e8918. doi: 10.1371/journal.pone.0089186</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Liu CH, Kuo SW, Ko WJ, Tsai PR, Wu SW, Lai CH, et al. Early measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation. Sci Rep. 2017; 7(1): 1021. doi: 10.1038/s41598-017-01225-1</mixed-citation><mixed-citation xml:lang="en">Liu CH, Kuo SW, Ko WJ, Tsai PR, Wu SW, Lai CH, et al. Early measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation. Sci Rep. 2017; 7(1): 1021. doi: 10.1038/s41598-017-01225-1</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Xie M, Cheng B, Ding Y, Wang C, Chen J. Correlations of IL- 17 and NF-κB gene polymorphisms with susceptibility and prognosis in acute respiratory distress syndrome in a Chinese population. Biosci Rep. 2019; 39(2): BSR20181987. doi: 10.1042/BSR20181987</mixed-citation><mixed-citation xml:lang="en">Xie M, Cheng B, Ding Y, Wang C, Chen J. Correlations of IL-17 and NF-κB gene polymorphisms with susceptibility and prognosis in acute respiratory distress syndrome in a Chinese population. Biosci Rep. 2019; 39(2): BSR20181987. doi: 10.1042/BSR20181987</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Shi T, Vennard S, Mahdy S, Nair H. Risk factors for RSV associated acute lower respiratory infection poor outcome and mortality in young children: A systematic review and meta-analysis. J Infect Dis. 2021: jiaa751. doi: 10.1093/infdis/jiaa751</mixed-citation><mixed-citation xml:lang="en">Shi T, Vennard S, Mahdy S, Nair H. Risk factors for RSV associated acute lower respiratory infection poor outcome and mortality in young children: A systematic review and meta-analysis. J Infect Dis. 2021: jiaa751. doi: 10.1093/infdis/jiaa751</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
